NeuroPace Future Growth
Future criteria checks 2/6
NeuroPace is forecast to grow earnings and revenue by 31.9% and 20.4% per annum respectively while EPS is expected to grow by 35.4% per annum.
Key information
31.9%
Earnings growth rate
35.4%
EPS growth rate
Medical Equipment earnings growth | 16.6% |
Revenue growth rate | 20.4% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 13 May 2024 |
Recent future growth updates
Recent updates
Is NeuroPace (NASDAQ:NPCE) Weighed On By Its Debt Load?
Apr 12NeuroPace: Picking Up The Pace
Feb 25Why Investors Shouldn't Be Surprised By NeuroPace, Inc.'s (NASDAQ:NPCE) 58% Share Price Surge
Jan 22NeuroPace, Inc. (NASDAQ:NPCE) Stock Rockets 39% But Many Are Still Ignoring The Company
Apr 17NeuroPace announces U.S. distribution agreement with DIXI Medical
Aug 11NeuroPace EPS misses by $32.45, beats on revenue; issues guidance
Jun 03Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 109 | -18 | -14 | -12 | 6 |
12/31/2025 | 89 | -29 | -21 | -20 | 7 |
12/31/2024 | 76 | -33 | -21 | -21 | 7 |
3/31/2024 | 69 | -32 | -18 | -18 | N/A |
12/31/2023 | 65 | -33 | -20 | -20 | N/A |
9/30/2023 | 60 | -38 | -24 | -24 | N/A |
6/30/2023 | 55 | -42 | -29 | -29 | N/A |
3/31/2023 | 49 | -46 | -36 | -35 | N/A |
12/31/2022 | 46 | -47 | -37 | -37 | N/A |
9/30/2022 | 44 | -47 | -38 | -37 | N/A |
6/30/2022 | 43 | -43 | -35 | -35 | N/A |
3/31/2022 | 45 | -39 | -31 | -30 | N/A |
12/31/2021 | 45 | -36 | -25 | -25 | N/A |
9/30/2021 | 45 | -30 | -23 | -23 | N/A |
6/30/2021 | 47 | -26 | -24 | -24 | N/A |
3/31/2021 | 42 | -26 | -21 | -21 | N/A |
12/31/2020 | 41 | -24 | -22 | -22 | N/A |
12/31/2019 | 37 | -30 | -25 | -25 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NPCE is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: NPCE is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: NPCE is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: NPCE's revenue (20.4% per year) is forecast to grow faster than the US market (8.3% per year).
High Growth Revenue: NPCE's revenue (20.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NPCE's Return on Equity is forecast to be high in 3 years time